Millipore Sigma Vibrant Logo

239807 InSolution™ Cyclopamine-KAAD - Calbiochem

InSolution™ Cyclopamine-KAAD, CAS 306387-90-6, is a 1 mM solution in DMSO. A cell-permeable, potent analog of Cyclopamine. Inhibits Hedgehog signaling (IC50 = 20 nM) with lower toxicity.

InSolution™ Cyclopamine-KAAD - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: 3-Keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine

Primary Target: SmoA1
View This Product on Sigma-Aldrich
239807
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Empirical Formula
C₄₄H₆₃Nl₃O₄

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
239807-50UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 50 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable potent analog of Cyclopamine (Cat. No. 239803) that specifically inhibits Hedgehog (Hh) signaling with similar or lower toxicity (IC50 = 20 nM in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells). Binds to SmoA1 and promotes its exit from the endoplasmic reticulum. Suppresses both ShhNp-induced pathway activity and SmoA1-induced reporter activity. Reported to cause regression of murine tumor allografts in vivo and induce rapid cell death in human medulloblastoma. Shown to sensitize human glioma cells to TRAIL-induced apoptosis. The solid form of this compound (Cat. No. 239804) is also available.
      Catalogue Number239807
      Brand Family Calbiochem®
      Synonyms3-Keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine
      References
      ReferencesSiegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.
      Product Information
      FormLiquid
      FormulationA 1 mM (50 µg/72 µL) solution of Cyclopamine-KAAD (Cat. No. 239804) in DMSO.
      Hill FormulaC₄₄H₆₃Nl₃O₄
      Hygroscopic Hygroscopic
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationInSolution™ Cyclopamine-KAAD, CAS 306387-90-6, is a 1 mM solution in DMSO. A cell-permeable, potent analog of Cyclopamine. Inhibits Hedgehog signaling (IC50 = 20 nM) with lower toxicity.
      Biological Information
      Primary TargetSmoA1
      Purity≥70% by HPLC (sum of two isomers)
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/38

      Irritating to eyes and skin.
      S PhraseS: 26-36/37/39

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Irritant
      Storage ≤ -70°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Aliquots are stable for up to 6 months at -70°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      239807-50UGCN 04055977198928

      Documentation

      InSolution™ Cyclopamine-KAAD - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      InSolution™ Cyclopamine-KAAD - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      239807

      参考資料

      参考資料の概要
      Siegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-September-2012 JSW
      Synonyms3-Keto-N-(aminoethyl-aminocaproyl-dihydrocinnamoyl)cyclopamine
      DescriptionA cell-permeable potent analog of Cyclopamine (Cat. No. 239803) that specifically inhibits Hedgehog (Hh) signaling with similar or lower toxicity (IC50 = 20 nM in Shh-LIGHT2 assay; 50 nM in p2Ptch-/-cells; 500 nM in SmoA1-LIGHT cells). Binds to SmoA1 and promotes its exit from the endoplasmic reticulum. Suppresses both ShhNp-induced pathway activity and SmoA1-induced reporter activity. Reported to cause regression of murine tumor allografts in vivo and induce rapid cell death in human medulloblastoma. Shown to sensitize human glioma cells to TRAIL-induced apoptosis. The solid form of this compound (Cat. No. 239804) is also available.
      FormLiquid
      FormulationA 1 mM (50 µg/72 µL) solution of Cyclopamine-KAAD (Cat. No. 239804) in DMSO.
      Intert gas (Yes/No) Packaged under inert gas
      Structure formulaStructure formula
      Purity≥70% by HPLC (sum of two isomers)
      Storage Protect from light
      Avoid freeze/thaw
      ≤ -70°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C). Aliquots are stable for up to 6 months at -70°C.
      Toxicity Irritant
      ReferencesSiegelin, M.D. et al. 2009. Neurobiol. Dis. 34, 259.
      Watkins, D.N., et al. 2003. Nature 422, 313.
      Berman, D.M., et al. 2002. Science 297, 1559.
      Chen, J.K., et al. 2002. Proc. Natl. Acad. Sci. USA 99, 14071.
      Chen, J.K., et al. 2002. Genes Dev. 16, 2743.
      Frank-Kamenetsky, M., et al. 2002. J. Biol. 1, 10.
      Taipale, J., et al. 2000. Nature 406, 1005.